A microbiota-derived antigen drives CD4


Journal

Trends in immunology
ISSN: 1471-4981
Titre abrégé: Trends Immunol
Pays: England
ID NLM: 100966032

Informations de publication

Date de publication:
11 2022
Historique:
received: 12 09 2022
accepted: 23 09 2022
pubmed: 16 10 2022
medline: 2 11 2022
entrez: 15 10 2022
Statut: ppublish

Résumé

CD4

Identifiants

pubmed: 36243620
pii: S1471-4906(22)00207-1
doi: 10.1016/j.it.2022.09.012
pii:
doi:

Substances chimiques

Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

858-860

Subventions

Organisme : NIDDK NIH HHS
ID : R11 DK129950
Pays : United States

Commentaires et corrections

Type : CommentOn

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests No competing interest to declare.

Auteurs

Luisa Cervantes-Barragan (L)

Department of Microbiology and Immunology, Emory University, Atlanta, GA, USA. Electronic address: lcervantes@emory.edu.

Marco Colonna (M)

Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. Electronic address: mcolonna@wustl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH